USD 0.45
(-11.83%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | - USD | -100.0% |
2023 | 526 Thousand USD | -44.31% |
2022 | 944.47 Thousand USD | -18.72% |
2021 | 1.16 Million USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 149.73 Thousand USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 840.03 Thousand USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
2009 | - USD | 0.0% |
2008 | - USD | 0.0% |
2007 | - USD | 0.0% |
2006 | - USD | -100.0% |
2005 | 1.38 Million USD | 0.0% |
2004 | - USD | 0.0% |
2003 | - USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
1999 | - USD | 0.0% |
1998 | - USD | 0.0% |
1997 | - USD | 0.0% |
1996 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | - USD | 0.0% |
2024 Q2 | - USD | -100.0% |
2024 Q1 | 1.59 Million USD | 203.85% |
2024 Q4 | - USD | 0.0% |
2023 Q2 | 759.26 Thousand USD | -11.5% |
2023 Q3 | 630.03 Thousand USD | -17.02% |
2023 FY | 526 Thousand USD | -44.31% |
2023 Q1 | 857.97 Thousand USD | -9.16% |
2023 Q4 | 526 Thousand USD | -16.51% |
2022 Q1 | 1.1 Million USD | -4.64% |
2022 Q2 | 1.07 Million USD | -2.63% |
2022 Q3 | 1.03 Million USD | -4.35% |
2022 FY | 944.47 Thousand USD | -18.72% |
2022 Q4 | 944.47 Thousand USD | -8.48% |
2021 Q4 | 1.16 Million USD | -81.0% |
2021 Q1 | 5.79 Million USD | 0.0% |
2021 Q2 | 6.03 Million USD | 4.12% |
2021 FY | 1.16 Million USD | 0.0% |
2021 Q3 | 6.11 Million USD | 1.39% |
2020 Q4 | - USD | -100.0% |
2020 Q1 | 126.93 Thousand USD | -15.23% |
2020 FY | - USD | -100.0% |
2020 Q3 | 7731.00 USD | -95.01% |
2020 Q2 | 154.87 Thousand USD | 22.01% |
2019 Q4 | 149.73 Thousand USD | -35.3% |
2019 Q3 | 231.42 Thousand USD | 0.0% |
2019 Q2 | - USD | -100.0% |
2019 Q1 | 93.43 Thousand USD | 0.0% |
2019 FY | 149.73 Thousand USD | 0.0% |
2018 FY | - USD | -100.0% |
2018 Q2 | - USD | -100.0% |
2018 Q1 | 702.83 Thousand USD | -16.33% |
2018 Q4 | - USD | 100.0% |
2018 Q3 | -8.87 Million USD | 0.0% |
2017 Q2 | - USD | 100.0% |
2017 FY | 840.03 Thousand USD | 0.0% |
2017 Q3 | 822.34 Thousand USD | 0.0% |
2017 Q1 | -3.77 Million USD | 0.0% |
2017 Q4 | 840.03 Thousand USD | 2.15% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 Q3 | -31.43 Thousand USD | 0.0% |
2013 Q4 | - USD | 100.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | 1.00 USD | 0.0% |
2013 Q2 | - USD | -100.0% |
2012 Q2 | - USD | 100.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | -16.6 Thousand USD | 0.0% |
2011 Q3 | -528.22 Thousand USD | 0.0% |
2011 Q4 | - USD | 100.0% |
2011 FY | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2010 FY | - USD | 0.0% |
2010 Q4 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 0.0% |
2009 Q3 | - USD | 0.0% |
2009 FY | - USD | 0.0% |
2009 Q4 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2009 Q1 | - USD | 0.0% |
2008 Q4 | - USD | 0.0% |
2008 Q1 | - USD | 0.0% |
2008 FY | - USD | 0.0% |
2008 Q2 | - USD | 0.0% |
2008 Q3 | - USD | 0.0% |
2007 Q1 | - USD | 0.0% |
2007 FY | - USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q4 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q3 | 1.68 Million USD | 0.0% |
2006 Q4 | - USD | -100.0% |
2006 FY | - USD | -100.0% |
2006 Q2 | - USD | -100.0% |
2006 Q1 | 1.68 Million USD | 21.55% |
2005 Q4 | 1.38 Million USD | 61.54% |
2005 Q3 | 855.61 Thousand USD | 25.17% |
2005 Q2 | 683.55 Thousand USD | 51.48% |
2005 Q1 | 451.25 Thousand USD | 0.0% |
2005 FY | 1.38 Million USD | 0.0% |
2004 FY | - USD | 0.0% |
2004 Q4 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 Q1 | - USD | 0.0% |
2004 Q2 | - USD | 0.0% |
2003 Q2 | - USD | 0.0% |
2003 Q1 | - USD | 0.0% |
2003 FY | - USD | 0.0% |
2003 Q3 | 303.93 Thousand USD | 0.0% |
2003 Q4 | - USD | -100.0% |
2002 Q2 | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2000 Q1 | -452.29 Thousand USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q2 | - USD | 100.0% |
2000 Q3 | - USD | 0.0% |
2000 Q4 | - USD | 0.0% |
1999 Q1 | - USD | 0.0% |
1999 FY | - USD | 0.0% |
1999 Q4 | - USD | 0.0% |
1999 Q3 | - USD | 0.0% |
1999 Q2 | - USD | 0.0% |
1998 Q3 | -500 Thousand USD | 0.0% |
1998 FY | - USD | 0.0% |
1998 Q1 | - USD | 0.0% |
1998 Q2 | - USD | 0.0% |
1998 Q4 | - USD | 100.0% |
1997 Q1 | -300 Thousand USD | 0.0% |
1997 Q2 | - USD | 100.0% |
1997 Q4 | - USD | 100.0% |
1997 Q3 | -100 Thousand USD | 0.0% |
1997 FY | - USD | 0.0% |
1996 FY | - USD | 0.0% |
1996 Q4 | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
AIM ImmunoTech Inc. | -1.18 Million USD | 100.0% |
Ampio Pharmaceuticals, Inc. | 1.00 USD | 100.0% |
Armata Pharmaceuticals, Inc. | - USD | NaN% |
Actinium Pharmaceuticals, Inc. | - USD | NaN% |
Azitra, Inc. | -215.21 Thousand USD | 100.0% |
Can-Fite BioPharma Ltd. | - USD | NaN% |
Chromocell Therapeutics Corporation | - USD | NaN% |
Calidi Biotherapeutics, Inc. | - USD | NaN% |
CEL-SCI Corporation | 2.24 Million USD | 100.0% |
iBio, Inc. | - USD | NaN% |
Lineage Cell Therapeutics, Inc. | - USD | NaN% |
MAIA Biotechnology, Inc. | - USD | NaN% |
Matinas BioPharma Holdings, Inc. | - USD | NaN% |
Navidea Biopharmaceuticals, Inc. | 427.34 Thousand USD | 100.0% |
NovaBay Pharmaceuticals, Inc. | 2.87 Million USD | 100.0% |
NanoViricides, Inc. | - USD | NaN% |
Oragenics, Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
BiomX Inc. | - USD | NaN% |
Protalix BioTherapeutics, Inc. | 19.04 Million USD | 100.0% |
Scorpius Holdings, Inc. | 909.15 Thousand USD | 100.0% |
Theriva Biologics, Inc. | - USD | NaN% |